Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Supaglutide

A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)

Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2/3 · Completed · Enrollment 547

NCT04994288

ArmPopulationDoseWeeksEstimandWeight change
Supaglutide RP3D high doseT2D onlyn/rn/rn/rn/r
supaglutide RD3D Low doseT2D onlyn/rn/rn/rn/r
placeboT2D onlyn/rn/rn/rn/r